Skip to main content
. 2018 Apr 4;11:49. doi: 10.1186/s13045-018-0583-7

Fig. 1 .

Fig. 1

Cumulative ≥CR rates by time. ≥CR, complete response or better; <CR, less than complete response; KRd, carfilzomib, lenalidomide, and dexamethasone; Rd, lenalidomide and dexamethasone. aData are from safety population: cumulative ≥CR rates achieved according to time from treatment start